We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Misshapen Erythrocytes Detected by Light Scattering

By LabMedica International staff writers
Posted on 14 Nov 2011
A technique allows doctors to ascertain the healthy shape of red blood cells in just a few seconds by analyzing the light scattered off hundreds of cells at a time. More...


The method called Fourier Transform Light Scattering (FTLS) was developed on individual red blood cells (RBCs), where the pattern changed significantly with the diameter and dimple width of the cells.

Scientists at the University of Illinois (UIUC; Urbana-Champaign, IL, USA) pioneered the technique that will allow physicians to ascertain whether red blood cells have healthy shapes or are distorted. This is accomplished by measuring the scattered light from hundreds of cells simultaneously. The theory was that if light was shone on a sample of blood and analyzed, the light scattering off that sample, would yield a pattern, a sort of signature produced by the way light interacts with itself in a three-dimensional space. That pattern would be different from the pattern collected from blood containing mostly misshapen cells.

These light-cell interactions were too complicated to analyze with the usual mathematical tools The UIUC team applied the Born approximation to their findings and calculated what the appropriate scattering signature for healthy cells should be. The investigators then used this new healthy cell signature to identify the correct morphology of cells in a blood smear. The novel technique may allow for faster, accurate blood tests that could help doctors diagnose various types of anemia, and could be especially useful in resource-poor areas of the world.

A healthy erythrocyte looks like a disc with a depression, called a dimple, in the top and bottom. Stressed RBCs often have deeper dimples than healthy ones, giving the cells a deflated look; others may have shallow dimples or no dimples at all. Misshapen RBCs are a sign of serious illnesses, such as malaria and sickle cell anemia. Until recently, the only way to assess whether a person's erythrocytes were the correct shape was to look at them individually under a microscope, a time-consuming process for pathologists. The study was published in October 2011 in the journal Biomedical Optics Express.

Related Links:

University of Illinois




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
New
Automated Coagulation Analyzer
Hemolumi H6
New
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.